1800-272-662
Shopping Cart 0
countryflagAU
Login

Auxly Cannabis Group Inc

Healthcare CA XLY

0.12CAD
-0.005(4.00%)

Last update at 2026-03-10T19:55:00Z

Day Range

0.120.12
LowHigh

52 Week Range

0.050.19
LowHigh

Fundamentals

  • Previous Close 0.12
  • Market Cap209.01M
  • Volume456070
  • P/E Ratio3.88
  • Dividend Yield-%
  • EBITDA44.62M
  • Revenue TTM146.00M
  • Revenue Per Share TTM0.11
  • Gross Profit TTM 86.93M
  • Diluted EPS TTM0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -0.35600M -47.74900M -136.55500M -50.24000M -88.11200M
Minority interest - - 0.00000M 0.01M -4.41100M
Net income -16.34800M -44.51100M -130.29300M -45.91000M -87.43100M
Selling general administrative 29.78M 39.78M 37.54M 36.12M 43.25M
Selling and marketing expenses 10.95M 0.50M 13.13M 9.60M 5.61M
Gross profit 59.93M 21.28M 17.92M 19.29M 11.14M
Reconciled depreciation 10.28M 11.21M 21.58M 14.27M 9.38M
Ebit 14.10M -22.09800M -46.79300M -42.00800M -54.03000M
Ebitda 24.38M -10.88900M -25.21700M -27.73500M -44.64600M
Depreciation and amortization 10.28M 11.21M 21.58M 14.27M 9.38M
Non operating income net other - - - - -
Operating income 14.71M -19.00500M -46.79300M -42.00800M -54.03000M
Other operating expenses 107.61M 120.08M 142.04M 122.77M 97.90M
Interest expense 15.04M 25.71M 21.58M 17.67M 13.04M
Tax provision 15.99M -3.23800M -6.26200M -4.33000M -0.68100M
Interest income 0.98M 0.03M 0.34M 3.85M 20.41M
Net interest income -14.80100M -25.68300M -21.24100M -16.07700M -12.56600M
Extraordinary items - - 0.00000M 12.16M -1.53700M
Non recurring - - - - -
Other items - - - - -
Income tax expense 15.99M -3.23800M -6.26200M -4.33000M -0.68100M
Total revenue 122.33M 101.08M 94.47M 83.83M 50.80M
Total operating expenses 45.22M 40.28M 65.49M 58.23M 58.24M
Cost of revenue 62.40M 79.80M 76.55M 64.54M 39.66M
Total other income expense net -15.07000M -28.74400M -89.76200M -8.23200M -34.08200M
Discontinued operations - - - 12.16M -1.53700M
Net income from continuing ops -16.34800M -44.51100M -130.29300M -45.91000M -87.43100M
Net income applicable to common shares -16.34800M -44.51100M -130.29300M -33.73900M -85.42600M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 261.53M 261.90M 331.82M 450.42M 378.96M
Intangible assets 29.76M 29.88M 45.47M 74.20M 74.26M
Earning assets - - - - -
Other current assets - 1.52M 3.13M 14.93M 12.68M
Total liab 145.87M 210.86M 246.13M 242.31M 187.43M
Total stockholder equity 115.66M 51.05M 90.41M 212.52M 195.94M
Deferred long term liab - - - - -
Other current liab 3.75M 0.49M 0.71M 1.30M 7.36M
Common stock - 446.56M 444.76M 436.51M 394.57M
Capital stock 542.63M 446.56M 444.76M 436.51M 394.57M
Retained earnings -499.62000M -483.27200M -438.76100M -308.46800M -274.72900M
Other liab - - - 20.04M 22.49M
Good will - - 0.00000M 24.29M 28.59M
Other assets - - 0.09M 1.58M 1.78M
Cash 18.36M 16.16M 14.64M 14.75M 21.21M
Cash and equivalents - - 14.64M 14.75M 21.21M
Total current liabilities 123.29M 106.97M 92.69M 53.65M 45.01M
Current deferred revenue - 0.00000M - 0.29M 5.66M
Net debt 36.33M 142.88M 178.96M 175.35M 103.47M
Short term debt - 65.18M 58.93M 21.49M 4.75M
Short long term debt 51.60M 61.35M 54.67M 17.45M 3.28M
Short long term debt total - 159.04M 193.59M 190.10M 124.68M
Other stockholder equity - 39.50M -30.54200M 44.85M 41.60M
Property plant equipment - - 195.27M 226.48M 95.35M
Total current assets 76.61M 65.99M 89.90M 119.97M 91.87M
Long term investments 0.59M 1.09M 1.09M 3.90M 87.11M
Net tangible assets - - - 114.03M 93.09M
Short term investments 0.14M 0.14M 0.14M 0.14M 0.29M
Net receivables 21.75M 16.73M 17.53M 31.21M 13.47M
Long term debt 3.09M 81.38M 119.80M 151.36M 110.53M
Inventory 34.00M 31.43M 54.46M 58.94M 44.22M
Accounts payable 44.90M 41.30M 33.05M 30.57M 27.24M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 48.26M 84.41M 84.48M 76.09M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 5.98M 0.09M 1.58M 1.78M
Deferred long term asset charges - - - - -
Non current assets total 184.92M 195.92M 241.92M 330.45M 287.09M
Capital lease obligations 13.79M 16.31M 19.12M 21.30M 10.88M
Long term debt total - - 134.67M 168.61M 119.94M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.44500M -1.55700M 1.18M 9.34M 6.01M
Change to liabilities - - 2.87M 0.18M 5.30M
Total cashflows from investing activities -0.44500M -1.55700M 1.18M 17.33M -14.53000M
Net borrowings -14.47600M -8.38800M - -19.55400M 7.17M
Total cash from financing activities -13.58500M -5.68500M 1.18M 26.40M 24.74M
Change to operating activities - - 9.98M -6.25600M 23.41M
Net income -16.34800M -44.51100M -130.29300M -45.91000M -87.43100M
Change in cash 2.75M 0.97M -0.11800M -5.90300M -22.92000M
Begin period cash flow 15.61M 15.19M 14.75M 20.66M 44.13M
End period cash flow 18.36M 16.16M 14.64M 14.75M 21.21M
Total cash from operating activities 16.78M 8.21M -2.48100M -49.62900M -33.12800M
Issuance of capital stock 0.00000M 3.13M 7.94M 44.94M 12.72M
Depreciation 10.28M 11.21M 21.58M 14.27M 9.38M
Other cashflows from investing activities 2.22M 0.05M 10.37M -0.00300M -0.16300M
Dividends paid - - - - -
Change to inventory 1.57M 12.71M -3.21500M -6.93000M -19.48900M
Change to account receivables -5.82700M 0.80M 10.41M -16.65400M -8.97200M
Sale purchase of stock 1.50M 3.13M 7.94M 46.15M 12.91M
Other cashflows from financing activities -0.61200M -0.43100M 15.51M 49.27M 19.14M
Change to netincome - - - -0.50600M 43.00M
Capital expenditures 2.76M 1.60M 9.19M 0.38M 20.73M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.05400M 17.86M 20.04M -29.65700M 1.40M
Stock based compensation 5.04M 1.64M 4.02M 1.43M 4.35M
Other non cash items 1.87M 25.25M 88.43M 14.56M 39.85M
Free cash flow 14.02M 6.61M -11.67300M -50.00700M -53.85700M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
XLY
Auxly Cannabis Group Inc		 -0.005 4.00% 0.12 3.88 11.36 1.20 0.98 1.40 3.79
BHC
Bausch Health Companies Inc		 0.08 1.10% 7.33 5.94 1.34 0.29 18.74 2.18 6.64
CURA
Curaleaf Holdings Inc.		 0.02 0.65% 3.08 - 138.89 1.90 2.05 1.88 11.75
CRON
Cronos Group Inc		 0.01 0.29% 3.44 23.40 32.26 10.16 0.92 1.27 -1.9458
TLRY
Tilray Inc		 -0.14 1.40% 9.83 - 1000.00 1.34 0.56 1.09 -2.299

Reports Covered

Stock Research & News

View All

Profile

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company offers cannabis products under various forms, including milled and dried flowers, vape cartridges, infused pre-rolls, pre-rolled, all- in-one vapes, edibles, concentrates, oils, and softgels under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

Auxly Cannabis Group Inc

777 Richmond Street West, Toronto, ON, Canada, M6J 0C2

Key Executives

Name Title Year Born
Mr. Hugo M. Alves CEO & Director 1972
Mr. Michael David Lickver Pres 1986
Mr. Brian Schmitt Chief Financial Officer NA
Mr. Ron Fichter Gen. Counsel & Corp. Sec. NA
Mr. Andrew MacMillan Sr. VP of Commercial NA
Mr. Alan Cooke Sr. VP of Operations NA
Ms. Carla Nawrocki Sr. VP of Corp. Devel. & Strategy NA
Mr. Ian Peter Rapsey Chief Creative Officer 1977
Mr. Kevin Furet Chief Cultivation & Genetics Officer NA
Mr. Vladimir Klacar Sr. VP of Regulatory Affairs & Planning 1989

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.